An efficient injectable formulation with block copolymer micelles for hydrophobic antitumor candidate-pyridazinone derivatives.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nanomedicine

• Publication date

  2015-07-27

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.2217/nnm.15.66PMID 26214355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.

  2014cited by this paper
• Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents.

  2014cited by this paper
• Synthesis, spectroscopy, X-ray analysis and in vitro antiproliferative effect of ferrocenylmethylene-hydrazinylpyridazin-3(2H)-ones and related ferroceno[d]pyridazin-1(2H)-ones

  2013cited by this paper
• Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity.

  2013cited by this paper
• Synthesis, antiproliferative and anti-inflammatory activities of some novel 6-aryl-2-(p-(methanesulfonyl)phenyl)-4,5-dihydropyridazi-3(2H)-ones.

  2013cited by this paper
• Pharmaceutical nanotechnology for oral delivery of anticancer drugs.

  2013cited by this paper
• Micelles of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) as a novel drug delivery vehicle for tacrolimus.

  2013cited by this paper
• Two novel nanoscale preparations of micelle and thermosensitive hydrogel for docetaxel to treat malignant tumor.

  2013cited by this paper
• PEG nanocages as non-sheddable stabilizers for drug nanocrystals.

  2012cited by this paper
• The Valley of Death in anticancer drug development: a reassessment.

  2012cited by this paper
• Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.

  2012cited by this paper
• Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones.

  2012cited by this paper
• Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro.

  2012cited by this paper
• Synthesis and anticonvulsant properties of 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea derivatives

  2011cited by this paper
• Preparation of Tacrolimus loaded micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone).

  2011cited by this paper
• Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo.

  2011cited by this paper
• Synthesis and characterization of new types of halogenated and alkylated imidazolidineiminothiones and a comparative study of their antitumor, antibacterial, and antifungal activities.

  2011cited by this paper
• Why pyridine containing pyrido[2,3-d]pyrimidin-7-ones selectively inhibit CDK4 than CDK2: insights from molecular dynamics simulation.

  2010cited by this paper
• Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents.

  2010cited by this paper
• Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro.

  2010cited by this paper
• Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

  2009cited by this paper
• Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.

  2009cited by this paper
• Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.

  2009cited by this paper
• Impact of nanotechnology on drug delivery.

  2009cited by this paper
• p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.

  2009cited by this paper
• A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel.

  2008cited by this paper
• The side effects of chemotherapeutic agents

  2008cited by this paper
• Application of Nanotechnology in Cancer Therapy and Imaging

  2008cited by this paper
• New frontiers in nanotechnology for cancer treatment.

  2008cited by this paper
• Synthesis and anti-inflammatory activity of certain piperazinylthienylpyridazine derivatives

  2007cited by this paper
• Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.

  2007cited by this paper
• Polymeric micelles for drug delivery.

  2006cited by this paper
• Nanotechnology Takes Aim at Cancer

  2005cited by this paper
• Cancer nanotechnology: opportunities and challenges

  2005cited by this paper
• Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.

  2004cited by this paper
• Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation.

  2004cited by this paper
• Proliferation of cancer cells despite CDK2 inhibition.

  2003cited by this paper
• Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

  2000cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)- pyridazinebutanoic acid (FK 838): a novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity.

  1999cited by this paper
• Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides.

  1997cited by this paper
• Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

  1966cited by this paper

• A new pyridazinone exhibits potent cytotoxicity on human cancer cells via apoptosis and poly-ubiquitinated protein accumulation

  2019cites this paper
• Diverse chemical and biological potentials of various pyridazine and pyridazinone derivatives

  2018cites this paper
• α-Lipoic acid stabilized DTX/IR780 micelles for photoacoustic/fluorescence imaging guided photothermal therapy/chemotherapy of breast cancer.

  2018cites this paper
• Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo.

  2017cites this paper
• Synthèse, étude chimique et pharmacologique d’une nouvelle série dérivée des pyridazin-3(2H)-ones

  2016cites this paper
• Mild photothermal therapy/photodynamic therapy/chemotherapy of breast cancer by Lyp-1 modified Docetaxel/IR820 Co-loaded micelles.

  2016cites this paper
• The evaluation of cellular uptake efficiency and tumor-targeting ability of MPEG–PDLLA micelles: effect of particle size

  2016cites this paper
• Targeting Therapy of Neuropilin-1 Receptors Overexpressed Breast Cancer by Paclitaxel-Loaded CK3-Conjugated Polymeric Micelles.

  2016cites this paper